Levy Adam Scott 4
4 · Mineralys Therapeutics, Inc. · Filed Jan 13, 2026
Insider Transaction Report
Form 4
Levy Adam Scott
CFO and Secretary
Transactions
- Sale
Common Stock
[F1][F2]2026-01-12$32.14/sh−10,758$345,723→ 8,638 total
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 14, 2023.
- [F2]The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $31.90 to $32.37. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (2) to this Form 4.
Signature
/s/ Adam Levy|2026-01-13